Other LanguagesWashington state has received a $6 million federal grant that will help connect expectant and parenting teens, women, fathers, and their families with health, education, and social services.
The Attorney General’s Office today released a formal Attorney General’s
Opinion in response to a request by Sen. Kevin Ranker, D-Orcas Island.
Ranker
asked if a public hospital district violates Initiative 120 if it
solely contracts with a health care provider that does not provide
reproductive care services such as contraception.
Wyeth Pharmaceutical to pay $491M, Washington state will receive $261K
Attorney General Bob Ferguson announced today that Washington has joined with other states and the federal government in a $491 million settlement against Wyeth Pharmaceuticals Inc., a pharmaceutical company acquired by Pfizer Inc. in 2009.
The Washington Attorney General’s Office (AGO) has successfully stopped deceptive marketing by a prescription drug discount card.
The AGO alleged Washington Drug Card falsely advertised their service as ‘Washington's Official Statewide Prescription Assistance Program,’ from March to April 2013. Washington Drug Card is a private company and is not affiliated or endorsed by any state governmental agency.
The Attorney General’s Office Medicaid Fraud Control Unit (MFCU) filed
felony criminal charges against Burnice R. Thompson in Thurston County
Superior Court today.
The Attorney General’s Office Medicaid Fraud Control Unit (MFCU) has
entered into diversion agreements with two defendants in connection with
falsifying timesheets as paid caregivers under the Medicaid program.
The Attorney General’s Office Medicaid Fraud Control Unit (MFCU) has
charged an Otis Orchards woman with one count of 1st degree theft and
two counts of making a false statement to obtain a Medicaid payment.
OLYMPIA—Washington has joined with other states and the federal government in a $500 million dollar settlement to resolve civil and criminal allegations against Ranbaxy, a generic pharmaceutical manufacturer based in Gurgaon, India. The company is alleged to have introduced adulterated—or tainted— drugs into interstate commerce, resulting in false or fraudulent claims being submitted to Washington’s Medicaid Program.
Attorney General Bob Ferguson announced today Washington has joined a
national settlement against the drug manufacturer Amgen, Inc., resolving
allegations that Amgen violated certain state false claims acts by
reporting inflated pricing data for its prescription drugs Aranesp,
Enbrel, Epogen, Neulasta, Neupogen, and Sensipar.
OLYMPIA-- Attorney General Bob Ferguson announced today that Washington has joined with other states and the federal government in a $22.5 million settlement with Par Pharmaceutical Companies, Inc. (“Par”). The states allege Par promoted sales of the drug Megace ES for uses not approved as safe and effective by the Food and Drug Administration (“FDA”) and not covered by the State Medicaid programs.